We observed that above-median sCD163 levels in CRC patients were associated with a shorter OS (p = 0.035), with a hazard ratio (HR) of 2.2 (95% confidence interval (CI) 1.0–4.6, p = 0.040). The gene discussed is CD163; the disease is colorectal carcinoma.